The finalized Medicare Advantage (MA) Rule 4208 includes important clarifications of enrollees’ rights to appeal denied inpatient stays. In my casual reading for clarification on another topic, which will be discussed in a future article, I noticed this statement on page 175:
“We note that similar policies exist for other types of coverage denials. For example, after an MA organization determines that covered inpatient care is no longer necessary, the enrollee may file an expedited appeal of the discharge decision to the QIO (Quality Improvement Organization). If the QIO upholds the MA organization’s decision, and the enrollee has left the hospital, in accordance with § 422.622(g)(2), the enrollee may continue their appeal to the ALJ (administrative law judge), Departmental Appeals Board (DAB), and ultimately, Federal court (if other conditions are met).”
Specifically, under 42 CFR §422.622, MA enrollees may initiate an expedited appeal through the QIO when their plan determines that continued inpatient care is no longer necessary. This marks a critical shift in the landscape for hospitals and case management teams, especially as they grapple with increasingly aggressive denial practices from MA plans for continued stay hospitalizations – particularly for those untimely authorizations and post-acute denials. There have been increasing reports of MA organizations not only denying continued inpatient hospital days, but simultaneously delaying or denying authorizations for medically necessary post-acute care placements.
Traditionally, hospitals have issued the Important Message from Medicare (IMM) only in the parameters of the physician-expected and initiated discharge, in a similar construct to guidance for Medicare fee-for-service (FFS) beneficiaries. However, MA enrollees have distinct rights under §422.622 that differ from the FFS model. According to the regulation and operational guidance, once an MA organization issues a formal denial of continued hospital coverage, hospitals are responsible for informing patients of their right to request immediate QIO review, even if the patient remains hospitalized.
The guidance specifically states that “an enrollee has a right to request an immediate review by the QIO when an MA organization or hospital (acting directly or through its utilization committee), with physician concurrence, determines that inpatient care is no longer necessary.” Note that this statement does not cite all hospital care services, but specifically inpatient hospital services.
Thus, the IMM should be provided alongside the MA plan’s denial notice, and case management/utilization review (CM/UR) teams should actively engage patients regarding their expedited appeal options. If the patient elects to appeal, they may contact the QIO directly, triggering an expedited review. Under section (c), the Centers for Medicare & Medicaid Services (CMS) confirms that the burden of proof is on the MA organization to prove to the QIO why the patient discharge is the correct decision, either on the basis of medical necessity or based on other Medicare coverage policies.
This process introduces several operational changes that CM/UR teams may want to consider. Once a notice of continued non-coverage is received from the MA plan, UM/CM teams will want to convene immediately, review with the attending for concurrence, and provide notice of denial to the patient with the IMM. This will notify the patient of their appeal rights to the QIO, and should the patient elect to appeal, the QIO would review to either support continued stay approval from the MA plan or push for timely authorization and support for needed post-acute placement.
By embedding the QIO appeal process earlier, when the denial is issued, rather than at discharge, hospitals can better protect patients, address financial inequalities regarding inpatient services, and challenge inappropriate payer behaviors that compromise safe discharge planning.
